Compare Mesoblast Limited (MESO) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Payoneer Global Inc — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Payoneer Global Inc trades at $7.13 (market cap $2.41B). The key difference: Mesoblast Limited and Payoneer Global Inc are close in size by market cap, and Payoneer Global Inc is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| MESO | PAYO | |
|---|---|---|
Market Cap | $2.17B | $2.41B |
Sector | Technology | Technology |
52-Week High | $20.96 | $7.42 |
52-Week Low | $12.88 | $4.27 |
Enterprise Value | $2.17B | $2.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Payoneer Global (PAYO) trades at $7.12, unchanged on the day, with a bullish technical signal driven by moving averages. The company reported Q1 2026 EPS of $0.06, beating expectations, but faces scrutiny over its proposed acquisition by Nuvei for $7.40 per share. Revenue grew to $821 million in 2025, though net income fell to $73 million. Analyst consensus is 60% buy with a $8.20 price target, suggesting moderate upside from current levels.
The outlook is mixed: the acquisition offers a near-term floor but may undervalue growth potential. Risks include integration challenges and earnings volatility. Upside depends on execution of expansion initiatives like the new India tech hub. Investors should weigh acquisition certainty against long-term standalone value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
